Tadashi Matsushita

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Venues

Scientific reports

Blood

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Tadashi Matsushita, Amy Shapiro, Aby Abraham, Pantep Angchaisuksiri, Giancarlo Castaman, Katarina Cepo, Roseline d'Oiron, Melissa Frei-Jones, Ai-Sim Goh, Jesper Haaning, Sanja Hald Jacobsen, Johnny Mahlangu, Mary Mathias, Keiji Nogami, Josephine Skovgaard Rasmussen, Oleksandra Stasyshyn, Huyen Tran, Kateryna Vilchevska, Laura Villarreal Martinez, Jerzy Windyga, Chur Woo You, Nadezhda Zozulya, Bulent Zulfikar, Victor Jiménez-Yuste, null null
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors. The New England journal of medicine 389 (9) (2023)

Tadashi Matsushita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tadashi Matsushita